Your session is about to expire
← Back to Search
SURGE Support Program for Cancer Trial Enrollment
Study Summary
This trial will help researchers learn more about how best to support patients in their decision to undergo genomic testing as part of a clinical trial.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer is in the stomach, blood, or chest area.I am unable to give my consent for participation.My cancer only needs regular monitoring.I am 18 years old or older.I speak a language that is not English or Spanish.I have an advanced cancer that needs treatment.I am Black, Latinx, or over 70 years old.
- Group 1: Arm B (informational video)
- Group 2: Arm A (standard of care)
- Group 3: Arm C (informational video and patient navigation)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the main goals of this clinical research endeavor?
"According to Bristol-Myers Squibb, the primary metric for assessment will be PROFILE genomic testing completion rates over a 3 year time frame. Additionally, this study is observing secondary objectives which include determining consent rate of patients with insufficient tissue samples and no archival specimens available as well as exploring correlations between patient demographics and disease characteristics with clinical trial awareness/readiness."
Are there any available openings for prospective participants in this clinical trial?
"According to clinicaltrials.gov, this medical trial is not presently recruiting patients - the original posting was on November 1st 2022 and it was last updated on May 11th 2022. Although no longer seeking participants right now, there are a great deal of other research studies that are currently open for enrolment (1882)."
Share this study with friends
Copy Link
Messenger